| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Endocrinology, Ghent University Hospital, Ghent B-9000, Belgium
* To whom correspondence should be addressed. E-mail: jean.kaufman{at}ugent.be.
Aging in men is accompanied by a progressive, but individually variable decline of serum testosterone production, more than 20% of healthy men over 60 yr of age presenting with serum levels below the range for young men. Albeit the clinical picture of aging in men is reminiscent of that of hypogonadism in young men and decreased testosterone production appears to play a role in part of these clinical changes in at least some elderly men, the clinical relevancy of the age-related decline in sex steroid levels in men has not been unequivocally established. In fact, minimal androgen requirements for elderly men remain poorly defined and are likely to vary between individuals. Consequently, borderline androgen deficiency cannot be reliably diagnosed in the elderly, and strict differentiation between "substitutive" and "pharmacological" androgen administration is not possible. To date, only a few hundred elderly men have received androgen therapy in the setting of a randomized, controlled study, and many of these men were not androgen deficient. Most consistent effects of treatment have been on body composition, but to date there is no evidence-based documentation of clinical benefits of androgen administration to elderly men with normal or moderately low serum testosterone in terms of diminished morbidity or of improved survival or quality of life. Until the long-term risk-benefit ratio for androgen administration to elderly is established in adequately powered trials of longer duration, androgen administration to elderly men should be reserved for the minority of elderly men who have both clear clinical symptoms of hypogonadism and frankly low serum testosterone levels.
This article has been cited by other articles:
![]() |
P. Abidi, H. Zhang, S. M Zaidi, W.-J. Shen, S. Leers-Sucheta, Y. Cortez, J. Han, and S. Azhar Oxidative stress-induced inhibition of adrenal steroidogenesis requires participation of p38 mitogen-activated protein kinase signaling pathway J. Endocrinol., July 1, 2008; 198(1): 193 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schlatt, C. R Pohl, J. Ehmcke, and S. Ramaswamy Age-Related Changes in Diurnal Rhythms and Levels of Gonadotropins, Testosterone, and Inhibin B in Male Rhesus Monkeys (Macaca mulatta) Biol Reprod, July 1, 2008; 79(1): 93 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khosla, S. Amin, and E. Orwoll Osteoporosis in Men Endocr. Rev., June 1, 2008; 29(4): 441 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brown Skeletal muscle and bone: effect of sex steroids and aging Advan Physiol Educ, June 1, 2008; 32(2): 120 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jana, X. Yin, R. B Schiffer, J.-J. Chen, A. K Pandey, D. M Stocco, P. Grammas, and X. Wang Chrysin, a natural flavonoid enhances steroidogenesis and steroidogenic acute regulatory protein gene expression in mouse Leydig cells J. Endocrinol., May 1, 2008; 197(2): 315 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yan and T. R. Brown Cell Proliferation and Expression of Cell Cycle Regulatory Proteins that Control the G1/S Transition Are Age Dependent and Lobe Specific in the Brown Norway Rat Model of Prostatic Hyperplasia Endocrinology, January 1, 2008; 149(1): 193 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-T. Khaw, M. Dowsett, E. Folkerd, S. Bingham, N. Wareham, R. Luben, A. Welch, and N. Day Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study Circulation, December 4, 2007; 116(23): 2694 - 2701. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Giton, S. Urien, C. Born, J. Tichet, J. Guechot, J. Callebert, F. Bronsard, J. P. Raynaud, and J. Fiet Determination of Bioavailable Testosterone [Non Sex Hormone Binding Globulin (SHBG)-Bound Testosterone] in a Population of Healthy French Men: Influence of Androstenediol on Testosterone Binding to SHBG Clin. Chem., December 1, 2007; 53(12): 2160 - 2168. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Araujo, G. R. Esche, V. Kupelian, A. B. O'Donnell, T. G. Travison, R. E. Williams, R. V. Clark, and J. B. McKinlay Prevalence of Symptomatic Androgen Deficiency in Men J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4241 - 4247. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Braunstein Gynecomastia N. Engl. J. Med., September 20, 2007; 357(12): 1229 - 1237. [Full Text] [PDF] |
||||
![]() |
P. Crabbe, V. Bogaert, D. De Bacquer, S. Goemaere, H. Zmierczak, and J. M. Kaufman Part of the Interindividual Variation in Serum Testosterone Levels in Healthy Men Reflects Differences in Androgen Sensitivity and Feedback Set Point: Contribution of the Androgen Receptor Polyglutamine Tract Polymorphism J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3604 - 3610. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Nielsen, C. Hagen, K. Wraae, K. Brixen, P. H. Petersen, E. Haug, R. Larsen, and M. Andersen Visceral and Subcutaneous Adipose Tissue Assessed by Magnetic Resonance Imaging in Relation to Circulating Androgens, Sex Hormone-Binding Globulin, and Luteinizing Hormone in Young Men J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2696 - 2705. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B Yeap, O. P Almeida, Z. Hyde, P. E Norman, S A P. Chubb, K. Jamrozik, and L. Flicker In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study Eur. J. Endocrinol., May 1, 2007; 156(5): 585 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Dhooge, N. Van Larebeke, F. Comhaire, and J.-M. Kaufman Regional Variations in Semen Quality of Community-Dwelling Young Men From Flanders Are Not Paralleled by Hormonal Indices of Testicular Function J Androl, May 1, 2007; 28(3): 435 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dechaud, A. Denuziere, S. Rinaldi, J. Bocquet, H. Lejeune, and M. Pugeat Age-Associated Discrepancy between Measured and Calculated Bioavailable Testosterone in Men Clin. Chem., April 1, 2007; 53(4): 723 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Lapauw, S Goemaere, P Crabbe, J M Kaufman, and J B Ruige Is the effect of testosterone on body composition modulated by the androgen receptor gene CAG repeat polymorphism in elderly men? Eur. J. Endocrinol., March 1, 2007; 156(3): 395 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. W. Wu Guideline for Male Testosterone Therapy: A European Perspective J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 418 - 419. [Full Text] [PDF] |
||||
![]() |
T. G. Travison, A. B. Araujo, V. Kupelian, A. B. O'Donnell, and J. B. McKinlay The Relative Contributions of Aging, Health, and Lifestyle Factors to Serum Testosterone Decline in Men J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 549 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ostrowski, J. E. Kuhns, J. A. Lupisella, M. C. Manfredi, B. C. Beehler, S. R. Krystek Jr., Y. Bi, C. Sun, R. Seethala, R. Golla, et al. Pharmacological and X-Ray Structural Characterization of a Novel Selective Androgen Receptor Modulator: Potent Hyperanabolic Stimulation of Skeletal Muscle with Hypostimulation of Prostate in Rats Endocrinology, January 1, 2007; 148(1): 4 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Travison, A. B. Araujo, A. B. O'Donnell, V. Kupelian, and J. B. McKinlay A Population-Level Decline in Serum Testosterone Levels in American Men J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 196 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khosla Sex Hormone Binding Globulin: Inhibitor or Facilitator (or Both) of Sex Steroid Action? J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4764 - 4766. [Full Text] [PDF] |
||||
![]() |
A. L. Eriksson, M. Lorentzon, D. Mellstrom, L. Vandenput, C. Swanson, N. Andersson, G. L. Hammond, J. Jakobsson, A. Rane, E. S. Orwoll, et al. SHBG Gene Promoter Polymorphisms in Men Are Associated with Serum Sex Hormone-Binding Globulin, Androgen and Androgen Metabolite Levels, and Hip Bone Mineral Density J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5029 - 5037. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Basaria and A. S. Dobs Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4743 - 4752. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zitzmann, S. Faber, and E. Nieschlag Association of Specific Symptoms and Metabolic Risks with Serum Testosterone in Older Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4335 - 4343. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Nair, R. A. Rizza, P. O'Brien, K. Dhatariya, K. R. Short, A. Nehra, J. L. Vittone, G. G. Klee, A. Basu, R. Basu, et al. DHEA in Elderly Women and DHEA or Testosterone in Elderly Men N. Engl. J. Med., October 19, 2006; 355(16): 1647 - 1659. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Stewart Aging and Fountain-of-Youth Hormones N. Engl. J. Med., October 19, 2006; 355(16): 1724 - 1726. [Full Text] [PDF] |
||||
![]() |
P. Y. Liu, P. Y. Takahashi, P. D. Roebuck, and J. D. Veldhuis Age or Factors Associated with Aging Attenuate Testosterone's Concentration-Dependent Enhancement of the Regularity of Luteinizing Hormone Secretion in Healthy Men J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4077 - 4084. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. de Ronde, Y. T. van der Schouw, H. A.P. Pols, L. J.G. Gooren, M. Muller, D. E. Grobbee, and F. H. de Jong Calculation of Bioavailable and Free Testosterone in Men: A Comparison of 5 Published Algorithms Clin. Chem., September 1, 2006; 52(9): 1777 - 1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Ho, W.-Y. Tang, J. Belmonte de Frausto, and G. S. Prins Developmental Exposure to Estradiol and Bisphenol A Increases Susceptibility to Prostate Carcinogenesis and Epigenetically Regulates Phosphodiesterase Type 4 Variant 4 Cancer Res., June 1, 2006; 66(11): 5624 - 5632. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Minniti, V. Esposito, M. Piccirilli, A. Fratticci, A. Santoro, and M.-L. Jaffrain-Rea Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature Eur. J. Endocrinol., December 1, 2005; 153(6): 723 - 735. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |